Scarica l'app Stockscreener
5.84
4.26%
-0.26
Dopo l'orario di chiusura:
5.72
-0.12
-2.05%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABCL Giù?
Forum
Previsione
Precedente Chiudi:
$6.10
Aprire:
$6.14
Volume 24 ore:
5.50M
Relative Volume:
0.98
Capitalizzazione di mercato:
$1.75B
Reddito:
$38.03M
Utile/perdita netta:
$-146.40M
Rapporto P/E:
-11.23
EPS:
-0.52
Flusso di cassa netto:
$-121.38M
1 W Prestazione:
-1.18%
1M Prestazione:
+22.43%
6M Prestazione:
+144.35%
1 anno Prestazione:
+122.90%
Intervallo 1D:
$5.7743
$6.225
Intervallo di 1 settimana:
$5.3501
$6.2283
Portata 52W:
$1.8906
$6.515
Abcellera Biologics Inc Stock (ABCL) Company Profile
Nome
Abcellera Biologics Inc
Settore
Industria
Telefono
(604) 559-9005
Indirizzo
150 W 4TH AVENUE, VANCOUVER
Confronta ABCL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
5.84 | 1.68B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-07 | Ripresa | Leerink Partners | Outperform |
| 2024-08-20 | Downgrade | The Benchmark Company | Buy → Hold |
| 2024-02-22 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-10-13 | Ripresa | Piper Sandler | Overweight |
| 2023-02-28 | Iniziato | Cowen | Outperform |
| 2022-12-15 | Iniziato | Goldman | Buy |
| 2022-11-16 | Iniziato | Truist | Buy |
| 2021-12-21 | Iniziato | The Benchmark Company | Buy |
| 2021-11-19 | Iniziato | Piper Sandler | Overweight |
| 2021-01-05 | Iniziato | BMO Capital Markets | Outperform |
| 2021-01-05 | Iniziato | Berenberg | Buy |
| 2021-01-05 | Iniziato | Credit Suisse | Outperform |
| 2021-01-05 | Iniziato | SVB Leerink | Outperform |
| 2021-01-05 | Iniziato | Stifel | Buy |
Mostra tutto
Abcellera Biologics Inc Borsa (ABCL) Ultime notizie
Using flow based indicators on AbCellera Biologics Inc.July 2025 Decliners & Reliable Volume Spike Trade Alerts - newser.com
Will AbCellera Biologics Inc. stock maintain momentum in 2025Day Trade & Expert Approved Trade Ideas - newser.com
How to use a screener to detect AbCellera Biologics Inc. breakoutsPortfolio Update Summary & AI Based Buy and Sell Signals - newser.com
Custom watchlist performance reports with AbCellera Biologics Inc.2025 Volume Leaders & Community Consensus Trade Signals - newser.com
What’s next for AbCellera Biologics Inc. stock priceQuarterly Performance Summary & Precise Swing Trade Alerts - newser.com
Using R and stats models for AbCellera Biologics Inc. forecastingQuarterly Profit Summary & High Accuracy Investment Entry Signals - newser.com
Is AbCellera Biologics Inc. a candidate for recovery playMarket Performance Recap & Smart Swing Trading Alerts - newser.com
Is AbCellera Biologics Inc. stock a dividend growth opportunityGDP Growth & Reliable Intraday Trade Plans - newser.com
Published on: 2025-10-14 11:10:04 - newser.com
Is now a turning point for AbCellera Biologics Inc.Portfolio Gains Report & Accurate Buy Signal Notifications - newser.com
Analyzing recovery setups for AbCellera Biologics Inc. investorsQuarterly Trade Summary & Daily Price Action Insights - newser.com
How AbCellera Biologics Inc. (8QQ) stock behaves in tightening cyclesEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
How AbCellera Biologics Inc. stock benefits from tech adoption2025 Year in Review & Daily Momentum Trading Reports - newser.com
AbCellera Biologics Hits New 52-Week High of $6.51 - Markets Mojo
AbCellera Biologics (NASDAQ:ABCL) Hits New 1-Year HighStill a Buy? - MarketBeat
Why AbCellera Biologics Inc. (8QQ) stock could rally stronglyNew Guidance & Free Technical Pattern Based Buy Signals - newser.com
Analyzing AbCellera Biologics Inc. with risk reward ratio chartsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Real time alert setup for AbCellera Biologics Inc. performanceStop Loss & Weekly High Potential Stock Alerts - newser.com
Does AbCellera Biologics Inc. qualify in momentum factor screening2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Is AbCellera Biologics Inc. (8QQ) stock cheap vs fundamentalsWeekly Trend Report & Safe Swing Trade Setups - newser.com
Is AbCellera Biologics Inc. (8QQ) stock a top dividend aristocrat candidateEarnings Beat & Expert Curated Trade Setups - newser.com
AbCellera Biologics (NASDAQ:ABCL) Stock Price Up 7.9%Here's What Happened - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025 - PharmiWeb.com
AbCellera Biologics: Entering Growth Phase After A Pause (NASDAQ:ABCL) - Seeking Alpha
AbCellera Biologics Inc. recovery potential after sell off2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com
Forecasting AbCellera Biologics Inc. price range with options dataJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
Should you hold or exit AbCellera Biologics Inc. nowWeekly Stock Summary & Daily Stock Trend Reports - newser.com
Statistical indicators supporting AbCellera Biologics Inc.’s strengthQuarterly Market Review & Fast Gaining Stock Reports - newser.com
Leading vs lagging indicators on AbCellera Biologics Inc. performanceTrade Exit Summary & Short-Term High Return Ideas - newser.com
Is AbCellera Biologics Inc. stock safe for conservative investors2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Published on: 2025-10-05 03:44:08 - newser.com
AbCellera Biologics Hits Day High with 8.17% Surge in Stock Price - Markets Mojo
AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline - Yahoo
How high can AbCellera Biologics Inc. stock goRate Cut & Technical Pattern Recognition Alerts - newser.com
Abcellera Biologics Inc Azioni (ABCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):